Front. Cardiovasc. Med. Frontiers in Cardiovascular Medicine Front. Cardiovasc. Med. 2297-055X Frontiers Media S.A. 10.3389/fcvm.2022.1125572 Cardiovascular Medicine Retraction Retraction: Silencing CircHIPK3 sponges miR-93-5p to inhibit the activation of Rac1/PI3K/AKT pathway and improves myocardial infarction-induced cardiac dysfunction Frontiers Editorial Office *

Approved by: Masanori Aikawa, Brigham and Women's Hospital and Harvard Medical School, United States

 *Correspondence: Frontiers Editorial Office ✉ research.integrity@frontiersin.org

This article was submitted to Atherosclerosis and Vascular Medicine, a section of the journal Frontiers in Cardiovascular Medicine

 04 01 2023 2022 9 1125572 16 12 2022 16 12 2022 Copyright © 2023 Frontiers Editorial Office. 2023 Frontiers Editorial Office

This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

 A Retraction of the Original Research Article Silencing CircHIPK3 sponges miR-93-5p to inhibit the activation of Rac1/PI3K/AKT pathway and improves myocardial infarction-induced cardiac dysfunction by Wu, Y., Wu, M., Yang, J., Li, Y., Peng, W., Wu, M., Yu, C., and Fang, M. (2021). Front. Cardiovasc. Med. 8:645378. doi: 10.3389/fcvm.2021.645378

The journal retracts the 30 April 2021 article cited above.

Following publication, concerns were raised regarding the integrity of the images in the published figures. The authors failed to provide a satisfactory explanation and complete raw dataset during the investigation, which was conducted in accordance with Frontiers' policies. Given the concerns about the validity of the data and the figures, and the lack of complete raw data, the article has been retracted.

This retraction was approved by the Chief Editors of Cardiovascular Medicine and the Chief Executive Editor of Frontiers. The authors agree to this retraction.